Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
87.50
+0.64 (0.74%)
May 6, 2025, 4:00 PM EDT - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $4.98 billion as of May 6, 2025. Its market cap has increased by 5.82% in one year.
Market Cap
4.98B
Enterprise Value
4.79B
1-Year Change
5.82%
Ranking
Category
Stock Price
$87.50
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $4.98B, an increase of 398.22%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2025 | 4.96B | -39.97% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.90B |
| Johnson & Johnson | 373.49B |
| UnitedHealth Group | 364.15B |
| AbbVie | 336.95B |
| Novo Nordisk | 309.41B |
| Abbott Laboratories | 229.05B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |